M. Nechaeva
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 6
- Cancer Treatment and Pharmacology 3
- PARP inhibition in cancer therapy 3
-
- Advanced Breast Cancer Therapies 5
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Peter Schmid (5 shared papers)Hiroji Iwata (5 shared papers)Véronique Dièras (3 shared papers)Luciana Molinero (3 shared papers)Andreas Schneeweiß (3 shared papers)Sylvia Adams (3 shared papers)Sherene Loi (3 shared papers)Amreen Husain (2 shared papers)
- Journals
- Annals of Oncology (8 papers)Journal of Clinical Oncology (4 papers)Cancer Research (2 papers)International Journal of Gynecological Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesRussiaUnited Kingdom
In The Last Decade
M. Nechaeva
17 papers receiving 409 citations
M. Nechaeva's Hit Papers
Peers
Comparison fields: 5 of 37
- Oncology 295
- Cancer Research 81
- Immunology 87
- Pulmonary and Respiratory Medicine 120
- Neurology 22
Countries citing papers authored by M. Nechaeva
This map shows the geographic impact of M. Nechaeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Nechaeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Nechaeva more than expected).
Fields of papers citing papers by M. Nechaeva
This network shows the impact of papers produced by M. Nechaeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Nechaeva. The network helps show where M. Nechaeva may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Nechaeva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study Hit paper breakdown → | 2021 | 214 |
| 2 | 2019 | 60 | |
| 3 | 2016 | 35 | |
| 4 | 2020 | 23 | |
| 5 | 2016 | 18 | |
| 6 | 2020 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2016 | 9 | |
| 9 | 2020 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2019 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 1 | |
| 17 | Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy | 2015 | 1 |
About M. Nechaeva
M. Nechaeva is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Neurology and Epidemiology, having authored 17 papers that have together received 411 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Treatment and Pharmacology (3 papers), Barrier Structure and Function Studies (3 papers), PARP inhibition in cancer therapy (3 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Oncology (295 citations), Cancer Research (81 citations), Immunology (87 citations), Pulmonary and Respiratory Medicine (120 citations) and Neurology (22 citations). M. Nechaeva has collaborated with scholars based in United States, Russia and United Kingdom. Frequent co-authors include Peter Schmid, Hiroji Iwata, Véronique Dièras, Luciana Molinero, Andreas Schneeweiß, Sylvia Adams, Sherene Loi, Amreen Husain, Hope S. Rugo and Carlos H. Barrios. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, International Journal of Gynecological Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.